Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 7/20 | 1.00 |
| ▸ | BCHE | P06276 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 0.98 |
| ▸ | BLM | P54132 | 5/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.98 |
| ▸ | MAPT | P10636 | 4/20 | 0.98 |
| ▸ | RECQL | P46063 | 4/20 | 0.98 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.98 |
| ▸ | THRB | P10828 | 3/20 | 0.98 |
| ▸ | HPGD | P15428 | 3/20 | 0.98 |
| ▸ | CASP1 | P29466 | 3/20 | 0.98 |
| ▸ | CASP7 | P55210 | 3/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.98 |
| ▸ | TERT | O14746 | 3/20 | 0.65 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL14996 | 1.00 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| Iodide SCHEMBL29527724 | 1.00 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| Water SCHEMBL9106337 | 0.99 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| SCHEMBL55279 | 0.99 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| SCHEMBL30379131 | 0.99 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| Hydrochloric Acid SCHEMBL5482694 | 0.98 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| SCHEMBL16331307 | 0.98 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| Bromide SCHEMBL30669741 | 0.98 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| Bromide SCHEMBL290404 | 0.98 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| Alcohol SCHEMBL15758944 | 0.97 | ACHE (0.94) | ACHEBCHEMEN1BLMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10409 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618776-B2 | Multi-fluorescence image acquisition system and method, and application | SHANGHAI RUIYU BIOTECH CO., LTD. (CN) | 2026-05-05 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4728260-A2 | STAINING DYE-COATED COVER SLIP | Bonraybio Co., Ltd. (TW) | 2026-04-22 | — | — | EP | claimed |
| US-20260098790-A1 | REAGENT-COATED COVER SLIP | BONRAYBIO CO LTD (TW) | 2026-04-09 | — | — | US | claimed |
| US-20260086004-A1 | STAINING DYE-COATED COVER SLIP | BONRAYBIO CO LTD (TW) | 2026-03-26 | — | — | US | claimed |
| EP-4684002-A2 | THYROCYTES AND USES THEREOF | Lifenet Health (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4673154-A1 | CELL THERAPY FOR TREATING SYSTEMIC AUTOIMMUNE DISEASES | Juno Therapeutics, Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| WO-2025245349-A1 | METHODS FOR DETERMINING THE PERCENTAGE VIABILITY OF CELLS WITHIN CELL AGGREGATES | BLUEROCK THERAPEUTICS LP (US) | 2025-11-27 | — | — | WO | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4045908-A1 | EX VIVO TUMOR ANGIOGENESIS MODEL | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-08-24 | — | — | EP | claimed |
| WO-2022163845-A1 | INSPECTION SYSTEM, INSPECTION METHOD, PROGRAM, AND COMPUTER-READABLE STORAGE MEDIUM | 株式会社バランス・イースト | 2022-08-04 | — | — | WO | claimed |
| WO-2022143783-A1 | METHODS OF IDENTIFYING T-CELL MODULATING GENES | EDIGENE THERAPEUTICS (BEIJING) INC. (CN) | 2022-07-07 | — | — | WO | claimed |
| EP-4019646-A1 | METHODS AND KITS FOR DETECTING SPERM DNA FRAGMENTATION | Bonraybio Co., Ltd. (TW) | 2022-06-29 | — | — | EP | claimed |
| US-20220195492-A1 | METHODS AND KITS FOR DETECTING SPERM DNA FRAGMENTATION | BONRAYBIO CO LTD (TW) | 2022-06-23 | — | — | US | claimed |
| CN-114616322-A | Viable islet-like cell structure and preparation method thereof | 联合细胞胰岛股份公司 | 2022-06-10 | — | — | CN | claimed |
| WO-2022078524-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-04-21 | — | — | WO | claimed |
| EP-3526584-B1 | USES, METHODS, KITS, COMPOSITIONS AND ANTIBODIES FOR IDENTIFYING HEMATOPOIETIC CELL SUBTYPES | OSPEDALE SAN RAFFAELE SRL (IT) | 2022-04-06 | — | — | EP | claimed |
| EP-2045595-B1 | Cell analyser and cell analysing method | SYSMEX CORP (JP) | 2022-03-23 | — | — | EP | claimed |
| CN-114032277-A | Method for detecting drug sensitivity of tumor organoid based on staining method | 创芯国际生物科技(广州)有限公司 | 2022-02-11 | — | — | CN | claimed |